Skip Navigation

A Randomized Phase III Study of Brentuximab Vedotin SGN-35, IND 117117 for Newly Diagnosed High Risk Classical Hodgkin Lymphoma cHL in Children and Adolescents

Brief Summary

Type:
Lymphomas

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT02166463

Study #:
CMH - AHOD1331

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02166463

View Complete Trial Details & Eligibility at ClinicalTrials.gov